Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan,430022, China.
Theranostics. 2019 Aug 12;9(20):5839-5853. doi: 10.7150/thno.34480. eCollection 2019.
Wound dressings composed of natural polymers, such as type I collagen, possess good biocompatibility, water holding capacity, air permeability, and degradability, and can be used in wound repair. However, due to the persistent oxidative stress in the wound area, the migration and proliferation of fibroblasts might be suppressed, leading to poor healing. Thus, collagen-containing scaffolds are not suitable for accelerated wound healing. Antioxidant N-acetyl cysteine (NAC) is known to reduce the reactive oxygen species (ROS) and has been widely used in the clinic. Theoretically, the carboxyl group of NAC allows loading of graphene oxide (GO) for sustained release and may also enhance the mechanical properties of the collagen scaffold, making it a better wound-dressing material. Herein, we demonstrated an innovative approach for a potential skin-regenerating hybrid membrane using GO incorporated with collagen I and NAC (N-Col-GO) capable of continuously releasing antioxidant NAC. The mechanical stability, water holding capacity, and biocompatibility of the N-Col-GO hybrid membrane were measured . A 20 mm rat full-skin defect model was created to evaluate the repair efficiency of the N-Col-GO hybrid membrane. The vascularization and scar-related genes in the wound area were also examined. Compared to the Col only scaffold, N-Col-GO hybrid membrane exhibited a better mechanical property, stronger water retention capacity, and slower NAC release ability, which likely promote fibroblast migration and proliferation. Treatment with the N-Col-GO hybrid membrane in the rat wound model showed complete healing 14 days after application which was 22% faster than the control group. HE and Masson staining confirmed faster collagen deposition and better epithelization, while CD31 staining revealed a noticeable increase of vascularization. Furthermore, Rt-PCR demonstrated decreased mRNA expression of profibrotic and overexpression of anti-fibrotic factors indicative of the anti-scar effect. These findings suggest that N-Col-GO drug release hybrid membrane serves as a better platform for scarless skin regeneration.
由天然聚合物(如 I 型胶原)组成的创面敷料具有良好的生物相容性、保水性、透气性和可降解性,可用于创面修复。然而,由于创面区域持续存在氧化应激,成纤维细胞的迁移和增殖可能受到抑制,导致愈合不良。因此,含胶原的支架并不适合加速创面愈合。抗氧化剂 N-乙酰半胱氨酸(NAC)已被证明可以减少活性氧(ROS),并已广泛应用于临床。理论上,NAC 的羧基允许负载氧化石墨烯(GO)以实现持续释放,并且还可能增强胶原支架的机械性能,使其成为更好的创面敷料材料。在此,我们展示了一种使用 GO 结合 I 型胶原和 NAC(N-Col-GO)的潜在皮肤再生混合膜的创新方法,该混合膜能够持续释放抗氧化剂 NAC。我们测量了 N-Col-GO 混合膜的机械稳定性、保水能力和生物相容性。建立了 20mm 大鼠全层皮肤缺损模型,以评估 N-Col-GO 混合膜的修复效率。还检查了创面区域的血管生成和瘢痕相关基因。与仅含胶原的支架相比,N-Col-GO 混合膜表现出更好的机械性能、更强的保水能力和更慢的 NAC 释放能力,这可能促进成纤维细胞的迁移和增殖。在大鼠创面模型中,用 N-Col-GO 混合膜治疗 14 天后完全愈合,比对照组快 22%。HE 和 Masson 染色证实了更快的胶原蛋白沉积和更好的上皮化,而 CD31 染色显示血管化明显增加。此外,RT-PCR 显示促纤维化因子的 mRNA 表达减少,抗纤维化因子的表达上调,表明具有抗瘢痕作用。这些发现表明,N-Col-GO 药物释放混合膜是一种更好的无瘢痕皮肤再生平台。